Takeda is a global biopharmaceutical company with over 240 years of history, headquartered in Tokyo and operating across approximately 80 countries with around 50,000 employees. The company maintains significant operations in the United States, where it claims to be the largest life sciences employer in Massachusetts. Its business centres on research and development, drug discovery, and the delivery of medicines and vaccines across six core therapeutic areas: oncology, neuroscience, gastroenterology and inflammation, rare diseases, plasma-derived therapies, and vaccines.
The company's approach emphasises patient focus and scientific innovation as central to its mission. Takeda's stated values - integrity, fairness, honesty, and perseverance - guide its operations, with integrity positioned as foundational. The organisation operates on a commitment to discovering and delivering life-transforming treatments whilst creating what it describes as an exceptional people experience for its workforce.
Takeda's portfolio spans treatments for conditions ranging from inflammatory diseases to cancer, neurological disorders, and rare genetic conditions. The company's evolution from its origins as a traditional medicine shop in Osaka reflects a transformation into a diversified healthcare enterprise, combining its heritage in pharmacy with modern translational science and biopharmaceutical manufacturing capabilities.